Group II metabotropic glutamate receptor agonists and positive allosteric modulators as novel treatments for schizophrenia
2012 ◽
Vol 62
(3)
◽
pp. 1473-1483
◽
1999 ◽
Vol 42
(15)
◽
pp. 2816-2827
◽
2014 ◽
Vol 592
(6)
◽
pp. 1411-1421
◽
2010 ◽
Vol 639
(1-3)
◽
pp. 59-66
◽
1998 ◽
Vol 356
(2-3)
◽
pp. 149-157
◽
2012 ◽
pp. 143-185
◽
2008 ◽
Vol 28
(32)
◽
pp. 8003-8013
◽